Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.addr.2013.09.007 http://scihub22266oqcxt.onion/10.1016/j.addr.2013.09.007 C4464660!4464660 !24064465     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24064465 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Adv+Drug+Deliv+Rev 2014 ; 66 (ä): 90-100 Nephropedia Template TP {{tp|p=24064465 |t=2014. Molecular imaging for cancer diagnosis and surgery |pdf=|usr=}}{{24064465 }} gab.com Text Molecular imaging for cancer diagnosis and surgery JO: Adv Drug Deliv Rev http://www.kidney.de/pget.php?&tw=1&pmid=24064465 #FOAvip Novel molecular imaging techniques have the potential to significantly enhance the diagnostic and therapeutic approaches for cancer treatment. For solid tumors in particular, novel molecular enhancers for imaging modalities such as US, CT, MRI and PET may facilitate earlier and more accurate diagnosis and staging which are prerequisites for successful surgical therapy. Enzymatically activatable "smart" molecular MRI probes seem particularly promising because of their potential to image tumors before and after surgical removal without re-administration of the probe to evaluate completeness of surgical resection. Furthermore, the use of "smart" MR probes as part of screening programs may enable detection of small tumors throughout the body in at-risk patient populations. Dual labeling of molecular MR probes with fluorescent dyes can add real time intraoperative guidance facilitating complete tumor resection and preservation of important structures. A truly theranostic approach with the further addition of therapeutic agents to the molecular probe for adjuvant therapy is conceivable for the future. Twit Text FOAVip Molecular imaging for cancer diagnosis and surgery ????Adv Drug Deliv Rev http://www.kidney.de/pget.php?&tw=1&pmid=24064465 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24064465 #FOAvip English Wikipedia <ref>{{Cite pmid|24064465 }}</ref> Molecular imaging for cancer diagnosis and surgery #MMPMID24064465 Hussain T ; Nguyen QT Adv Drug Deliv Rev 2014[Feb]; 66 (ä): 90-100 PMID24064465 show ga Novel molecular imaging techniques have the potential to significantly enhance the diagnostic and therapeutic approaches for cancer treatment. For solid tumors in particular, novel molecular enhancers for imaging modalities such as US, CT, MRI and PET may facilitate earlier and more accurate diagnosis and staging which are prerequisites for successful surgical therapy. Enzymatically activatable "smart" molecular MRI probes seem particularly promising because of their potential to image tumors before and after surgical removal without re-administration of the probe to evaluate completeness of surgical resection. Furthermore, the use of "smart" MR probes as part of screening programs may enable detection of small tumors throughout the body in at-risk patient populations. Dual labeling of molecular MR probes with fluorescent dyes can add real time intraoperative guidance facilitating complete tumor resection and preservation of important structures. A truly theranostic approach with the further addition of therapeutic agents to the molecular probe for adjuvant therapy is conceivable for the future. |*Molecular Imaging [MESH] |Animals [MESH] |Humans [MESH] |Neoplasm Staging [MESH]Molecular imaging for cancer diagnosis and surgery (epmc).pdf DeepDyve Pubget Overpricing